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ABSTRACT: Microbial colonization of the mammalian intestine begins at birth, when from a sterile state a 
newborn infant is exposed to an external environment rich in various bacterial species. An important group 
of intestinal bacteria comprises bifidobacteria. Bifidobacteria represent major intestinal microbiota during 
the breast-feeding period. Animal milk contains all crucial nutrients for babies’ intestinal microflora. The 
aim of our work was to test the influence of different mammalian milk on the growth of bifidobacteria. The 
growth of seven strains of bifidobacteria in human milk, the colostrum of swine, cow’s milk, sheep’s milk, 
and rabbit’s milk was tested. Good growth accompanied by the production of lactic acid was observed not 
only in human milk, but also in the other kinds of milk in all three strains of Bifidobacterium bifidum of 
different origin. Human milk selectively supported the production of lactic acid of human bifidobacterial 
isolates, especially the Bifidobacterium bifidum species. The promotion of bifidobacteria by milk is species-
specific. Human milk contains a key factor for the growth of specific species or strains of human-origin 
bifidobacteria compared to other kinds of milk. In contrast, some components (maybe lysozyme) of human 
milk inhibited the growth of Bifidobacterium animalis. Animal-origin strains of bifidobacteria were not able 
to significantly grow even in milk of animal origin, with the exception of B. animalis subsp. lactis 1,2, which 
slightly grew in sheep’s milk.
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In normal conditions the mammalian gastro-
intestinal tract at birth is sterile. Since the birth, 
microorganisms coming from the environment 
start colonizing the intestinal tract of the young. 
The development of intestinal microflora depends 
on numerous factors, such as the type of birth, 
environmental contamination, sanitary conditions, 
and the geographical distribution of bacterial spe-
cies (Mackie et al., 1999; Orrhage and Nord, 1999; 
Mountzouris and Gibson, 2003). The dominating 
group of bacteria in the intestinal tract of breast-fed 
newborns comprises bifidobacteria. Mammalian 
milk promotes the development of favourable 
intestinal bacteria that can protect the intestinal 
tract from the proliferation of pathogenic bacteria. 
Mammalian milk is a heterogeneous complex of 
biological substances such as saccharides, mainly 
oligosaccharides, amino acids, essential nutrients, 
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vitamins, and minerals, all of which promoting 
the development of gastrointestinal microflora in 
the newborn during the first few days of its life. 
There are multiple variances between human and 
other kinds of mammalian milk. Human milk is 
richer than cow’s milk especially in the content of 
prebiotic oligosaccharides, minerals, vitamins, and 
antimicrobial compounds. Proteins found in human 
milk (lactoferrin, haptocorrin, immunoglobulins, 
lactoperoxidase, and lysozyme) protect the infants 
against infectious diseases (Lönnerdal, 2003). For 
instance, the levels of lysozyme naturally present 
in the milk of dairy animals are 1600–3000 times 
lower than those in human milk (up to 400 mg/l) 
(Chandan et al., 1968). Lysozyme is an enzyme 
which catalyzes the cleavage of the glycosidic 
linkage in peptidoglycan, the main component of 
the cell walls of bacteria (Phillips, 1966). It also 
contributes to the stimulation of beneficial gut 
microflora and maturation of the intestinal tract 
(Lönnerdal, 2003).
Other milk components that make human milk 
unique are prebiotic oligosaccharides, the third 
largest solid group of milk components after lac-
tose and lipids. Each kind of mammalian milk 
possesses different oligosaccharide contents and 
structures. Colostrum of humans and mature hu-
man milk contains 22~24 g/l and 12~13 g/l of 
oligosaccharides, respectively. Human milk oligo-
saccharides have a far more complicated structure 
(Newburg and Neubauer, 1995; Kunz et al., 2000) 
than oligosacharides in other mammalian milk; for 
instance, bovine milk normally contains 1–2 g/l 
of free saccharides other than lactose but larger 
amounts occur in the colostrum of cattle (Davis et 
al., 1983). The role of individual oligosaccharides 
in mammalian milk has not been fully investigated 
yet, particularly in the case of non-human oligo-
saccharides. Besides their bifidogenic effect, they 
are also perceived as the soluble receptor analogs 
that inhibit the attachment of pathogenic bacteria, 
viruses, and bacterial toxins to the mucosa of the 
colon of newborns (Newburg et al., 2005).
In our previous study, the growth of different spe-
cies of bifidobacteria in human milk was tested and 
significant differences were discovered (Rockova et 
al., 2011). The aim of the present work was to test 
the influence of different kinds of animal milk on 
the growth of bifidobacteria. In our previous re-
search, the resistance of bifidobacteria to lysozyme 
was tested and, therefore, the content of lysozyme 
in animal and human milk was tested, too.
MATERIAL AND METHODS
Bacterial strains
The list of bifidobacterial strains used is shown in 
Table 1. Three strains (2 B. bifidum and 1 B. longum) 
were isolated from infant faeces. Two strains of 
B. animalis were isolated from fermented milk 
products. The remaining two strains were isolated 
from commercial probiotic products. All strains 
were isolated and identified using biochemical tests 
and PCR, as described by Vlková et al. (2005). The 
subcultivation of bifidobacteria was performed in 
Wilkins-Chalgren broth supplemented with 5 g/l 
of soya peptone. Strains were stored in Wilkins-
Chalgren broth supplemented with soya peptone 
and glycerol (20% v/v) at –20°C.
Growth of bifidobacteria in milk
The human milk sample was obtained from the 
Institute for the Care of Mother and Child (Prague, 
Czech Republic). The donor mother had delivered 
her child three months previously. The animal kinds 
of milk (Holstein breed) were sourced from the 
Experimental Cowshed Station of the Czech Uni-
versity of Life Sciences Prague. Milk samples were 
pasteurized (62.5°C for 30 min), and then cooled 
in a water bath in order to kill pathogenic micro-
organisms but with minimal loss to the product’s 
intrinsic resistance factors and biologically active 
compounds (Packard, 1982; Ewaschuk et al., 2011).
The bifidobacteria in the milk samples were 
cultivated and enumerated as described by Rada 
et al. (2010). Briefly: bifidobacteria grown at 37°C 
for 24 h in Wilkins–Chalgren broth (Oxoid, Bas-
ingstoke, UK) were centrifuged (6000 g for 5 min), 
the supernatant was discarded, bacterial cells were 
flushed with saline and then finally re-suspended 
in the saline to be prepared for bacterial suspen-
sion (approximately 107 CFU/ml). The microtiter 
plate (Gama Group, Trhové Sviny, Czech Republic) 
contained 100 µl of milk sample, and each hole 
was inoculated with bifidobacterial suspension 
containing approximately 107 CFU/ml. After in-
cubation, the pH and lactic acid were determined 
by Reflektoquant equipment (Merck, Darmstadt, 
Germany). Following cultivation, bifidobacteria 
were evaluated using TPY agar modified by add-
ing mupirocin (100 mg/l) and acetic acid (1 ml/l), 
according to Rada and Petr (2000).
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Determination of lysozyme in milk samples
The human milk samples were collected from 
35 mothers and obtained from the Institute for 
the Care of Mother and Child (Prague, Czech 
Republic). The donors were mothers 10 ± 4 weeks 
after delivery. The samples of the macaque milk 
(Macaca mulatta) came from the Biotest (Konáro- 
vice, Czech Republic). Other animal milks were 
obtained from Experimental Cowshed Station of 
the Czech University of Life Sciences Prague. All 
milk samples were frozen immediately after col-
lection and stored at –30°C until used. Samples 
were thawed at 40°C in a water bath and homo- 
genized immediately before analysis. The lysozyme 
content in human milk was determined using the 
ELISA (Enzyme-Linked Immunosorbent Assay) 
Kit (Biomedical Technologies Inc., Stoughton, 
USA). For analysis, each sample was diluted at 
1 : 12 000. Briefly: ELISA is an indirect method 
that uses interaction with a specific antigen anti-
body complex to form an antigen-antibody. The 
sandwich ELISA assay for human lysozyme content 
of monoclonal antibody specific for lysozyme is 
bound to polystyrene wells, after incubation with 
samples; the plate is then washed and incubated 
with a second human lysozyme specific antibody 
and subsequently detected using Horseradish 
Peroxidase conjugate of Donkey anti-goat (sheep) 
IgG. The concentration of human lysozyme is pro-
portional to colour intensity. Colour (absorbance) 
was measured by the Multifunctional Micro Plate 
Reader (TECAN, Durham, USA) at 450 nm. Exact 
levels were obtained from a standard curve using 
purified human lysozyme.
The lysozyme content in all samples of milk was 
also determined using the agar plate (lyso-plate) 
technique (Osserman and Lawlor, 1966).
Statistical analyses
STATGRAPHICS Centurion XV.II software (Ver-
sion 15.2.05, 2007) was used to perform analyses 
of variance with Duncan’s multiple range tests at a 
confidence level of 95% for the differences among 
bifidobacterial counts and pH values for all experi-
mental groups. The significance of the contents of 
lysozyme in milks was tested by a Student’s t-test.
RESULTS AND DISCUSSION
The growth of bacteria in milk is shown in Table 1 
and the values of pH and lactic acid in Figures 1 and 2.
Growth in human milk
If the strains actually grew, they produced lactic 
acid and acetic acid in the approximate propor-
tion 3 : 2, because the bifidobacterial pathway 
yields 2.5 ATP molecules from 1 mol of fermented 
glucose, as well as 1.5 mol of acetate and 1 mol of 
Table 1. Growth of bifidobacteria (log CFU/ml) cultivated in mammalian milk samples at 37°C for 24 h under an-
aerobic conditions









Initial concentrations (log CFU/ml) 5.94 ± 0.46 6.00 ± 0.68 7.38 ± 0.25 8.16 ± 0.68 7.50 ± 0.20
B. animalis subsp. lactis 1 fermented milk product 4.53 ± 0.71a 5.48 ± 0.05a 7.06 ± 0.40b 8.07 ± 0.20b 8.67 ± 0.11d
B. animalis subsp. lactis 2 fermented milk product 4.61 ± 0.12a 6.83 ± 0.18cd 8.21 ± 0.01cd 8.50 ± 0.13c 8.55 ± 0.02cd
B. bifidum 1 probiotic capsule 8.70 ± 0.09b 7.18 ± 0.06d 6.78 ± 0.03b 7.45 ± 0.08a 9.36 ± 0.04f
B. bifidum 2 infant faeces 8.62 ± 0.00c 6.69 ± 0.44c 8.08 ± 0.17c 7.27 ± 0.10a 9.12 ± 0.20e
B. bifidum 3 infant faeces 8.21 ± 0.01d 7.17 ± 0.20d 8.23 ± 0.01cd 8.59 ± 0.03c 7.62 ± 0.07b
B. longum 1 infant faeces 6.58 ± 0.03de 5.80 ± 0.27ab 8.41 ± 0.04d 7.88 ± 0.33b 8.42 ± 0.01c
B. longum 2 probiotic capsule 7.70 ± 0.10e 6.00 ± 0.19b 6.38 ± 0.02a 8.91 ± 0.09d 6.49 ± 0.03a
values in columns with different superscripts differ (P < 0.05); differences among bifidobacterial counts were evaluated by 
the multiple range comparison with multiple range tests
data are means ± standard deviation (SD) of three measurements
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lactate (Palframan et al., 2003). Luxuriant growth 
of bifidobacteria in milk samples resulted in pro-
ducing lactic acid (> 1000 mg/l) and a final pH 
of around 4. All bifidobacterial strain species of 
B. bifidum and B. longum 2 were able to grow 
in the human milk sample tested, producing 
1672.5 mg of lactic acid on average (pH 4.2 ± 
0.37) and reaching colony counts from 6 to 8 log 
CFU/ml. One strain of human origin B. longum 1 
was not able to grow in human milk, producing 
a minimal quantity of lactate (260 mg/l, pH 5.2). 
The colony counts of this strain were the same 
before and after incubation.
Both bifidobacterial strains originating from 
animal milk (B. animalis) were inhibited by human 
milk. The colony counts of this strain decreased 
from 6 to 4.57 ± 0.42 log CFU/ml, and concentra-
tions of lactate were only 195 ± 35.36 mg/l (pH = 
5.65 ±0.35). Both strains of B. animalis were sus-
ceptible to lysozyme.
Growth in the colostrum of swine
Bifidobacterial strains were not able to grow in 
the colostrum of swine, but also no strains were 
inhibited by this sample of milk. Colony counts 
were 6.41 ± 0.74 log CFU/ml and values of lactate 
641.7 ± 254.2 mg/l (pH 5.7 ± 0.17). The exception 
was the strain B. bifidum 2 of human origin, reach-
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Figure 2. Lactate content (mg/l) in mammalian samples of milk cultured under anaerobic conditions at 37°C for 24 h
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Growth in cow’s and goat’s milk
Limited growth of bifidobacterial strains was ob-
served in cow’s and goat’s milk. The counts of colonies 
were almost the same before and after incubation (ini-
tial concentration approximately 7.82 log CFU/ml); 
the final concentration after incubation of bacteria in 
milk was approximately 7.84 log CFU/ml. In addition, 
bifidobacteria produced approximately 250 mg/l of 
lactate (pH > 5.5). These values demonstrate that 
strains were not able to grow in milk. Only two strains 
of human origin B. bifidum 1, 2 exhibited limited 
growth in goat’s milk, producing 1235 ± 0.0 mg/l of 
lactic acid with pH 5.0 ± 0.14.
Growth in rabbit’s milk
Rabbit’s milk stimulates the growth of some bifi-
dobacterial strains (Table 1, Figures 1 and 2). The 
animal strains B. animalis 1, 2 were not inhibited 
by this sample of milk, but also it did not support 
their growth. The small volume of this sample did 
not enable the authors to measure lactate. Only 
three strains of human origin B. bifidum 1, 2 and 
B. longum 2 had a limited growth in rabbit’s milk 
(Table 1, Figures 1 and 2); counts of the colony 
increased from 7.82 to 8.32 ± 1.59 log CFU/ml 
with pH 5.5 ± 0.87.
Although there are many differences in the 
composition of mammalian milks and numerous 
differences in the complexity and composition of 
milk saccharides, all kinds of milk share in com-
mon the fact that they are produced in mammary 
glands and their function is to support (promote) 
the development of any suckling young. Further-
more, the milk of almost all mammals contains 
lactose, either in a free form or at the reducing 
ends of oligosaccharides and it also contains a 
unique mixture of oligosaccharides (Urashima 
et al., 2001). Some oligosaccharides are species 
specific; for example, the colostrum of bovines 
contains ten sialyl oligosaccharides (Kuhn and 
Gauhe, 1965; Schneir and Rafelson, 1966; Veh 
et al., 1981), in which two kinds of sialic acid, 
Neu5Ac and Neu5Gc, are found, in contrast to 
human milk or human colostrum oligosaccharides, 
which contain only Neu5Ac (Urashima et al., 2001). 
Brinkman-Van den Linden et al. (2000) discovered 
that Neu5Gc is present in all mammals except for 
humans because of specific hominid mutation in 
CMP-sialic acid hydroxylase.
Bifidobacteria are fastidious organisms that require 
specific growth factors such as free amino acids and 
peptides (Cheng and Nagasawa, 1985). Human milk 
is considered a suitable medium for the growth of 
bifidobacteria because of its optimal composition 
of oligosaccharides and peptides. Only human milk 
fully supported the growth of some bifidobacterial 
strains of B. bifidum 1, 2, 3 and B. longum 2. Both 
animal strains B. animalis 1, 2 and one strain of hu-
man origin, B. longum 1, were significantly inhibited 
by human milk. While some kinds of milk seem to 
exhibit a nutrient deficiency for the growth, others 
distinctly promote the growth of some bifidobac-
terial strains. Only specific bifidobacterial strains, 
such as B. bifidum 1, 2 and B. longum 2, exhibited 
limited growth in animal kinds of milk.
Determination of lysozyme in milk samples
For determining lysozyme in human milk, the 
ELISA method and microbiological lyso-plate 
technique were used. There were significant differ-
ences in determinations of lysozyme as recorded by 
the ELISA kit and lyso-plate technique (Table 2). 
The values which the authors measured by the 
ELISA method were 2 times higher than values 
determined by the lyso-plate technique. The con-
centrations of lysozyme ranged 1–131.83 µg/ml 
and 17.43–184.02 µg/ml, as determined by the lyso-
plate technique and ELISA method, respectively. 
The authors found out that the ELISA method is 
a specific procedure for determining the lysozyme 
in samples. This method probably detected all 
the lysozyme in human milk, including molecules 
without antibacterial activity. In contrast, the 
lyso-plate technique is a method able to determine 
only biologically active lysozyme. To be honest, it 
should be noted, that the lyso-plate method can 
also be susceptible to other antimicrobial compo-
nents in milk. Chicken egg white is currently the 
major commercial source of lysozyme. Lysozyme 
from chicken egg whites is only 60% identical to 
human lysozyme. The fact that antibodies oppos-
ing human and chicken egg white lysozyme do not 
exhibit cross-interference points to significant 
structural differences.
Bifidobacteria are Gram-positive bacteria, which 
are more susceptible to lysozyme (antimicrobial 
enzyme EC 3.2.1.17) than Gram-negative bacte-
ria (Lönnerdal, 2003). Lysozyme is single chain 
protein of 123 amino acids found in many human 
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cells and tissues, human milk, and egg white (Field 
2005; Paramasivam et al., 2006). It hydrolyses 
β (1,4) linkage between N-acetylglucosamine and 
N-acetylmuramic acid in peptidoglycan of the 
bacterial cell wall. This non-specific immuno-
logical component is found in human milk at a 
concentration 3000 times higher than in milk 
from other animal species (Clare et al., 2003). 
Cow’s and goat’s milks possess very low levels of 
lysozyme (0.16 and 0.23 mg/l) relative to human 
milk (400 μg/ml) (Chandan et al., 1968; Clare et 
al., 2003), as confirmed by our results in Table 2.
It could be concluded that only human milk 
was able to support the growth of specific spe-
cies or strains of human origin bifidobacteria. 
Animal kinds of milk seem to be an insufficient 
environment for the growth of bifidobacteria, in-
cluding strains of animal origin, despite the high 
concentration of lactose and other nutrients in 
their content. In contrast, non-human mammalian 
milk appears to be quite suitable for the survival 
of bifidobacteria. Hence, for example, cow’s milk 
can be used for conserving industrial bifidobacte-
rial strains and milk-based food can contain live 
probiotic bacteria, including bifidobacteria.
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